Hyperfine (HYPR) Stock Price

Hyperfine Price

NYSE·CLOSED
0.94
​
Market closed

Revenue has compounded at 115.2% per year over the past 5 years to 13.56 M USD. Hyperfine's net margin stands at -262.3%, up from -4,333.8% several years earlier. Analysts set a median price target of 1.60 USD, implying 70.5% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Hyperfine stock price

Access this data via the Eulerpool API

Hyperfine business model & stock analysis

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.

Frequently asked questions about Hyperfine

Analysts currently set an average price target of 1.60 USD for the Hyperfine stock (median: 1.60 USD), implying +70.5 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Hyperfine stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Hyperfine to generate revenue of 20.17 M USD and earnings per share of -0.36 USD.

Converted at the current exchange rate, the Hyperfine share trades at 0.84 EUR (0.94 USD).

The expected revenue of Hyperfine is 20.17 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Hyperfine is -34.38 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Hyperfine is currently -2.57. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Hyperfine stock.

The price-to-sales ratio (P/S) of Hyperfine is currently 4.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Hyperfine stock.

The Eulerpool Quality Score for Hyperfine is 3/10.

The ISIN of Hyperfine is US44916K1060. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Hyperfine is HYPR. The ticker symbol is used to trade Hyperfine shares on the stock exchange.

Fair ValueTerminal
0.80 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
132,970.59 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website hyperfine.io
Currency
USD
Initial public offering
Jan 27, 2021
ISIN
US44916K1060
Cusip
44916K106
Market capitalization
94.42 M USDMicro Cap
52-Week Range
PEG
0.62
P/E ratio
P/Ee 2026
-2.57
P/Ee 2027
-2.74
P/Ee 2028
-2.90
P/Ee 2029
-3.03
P/S
P/Se
4.38
EV/EBIT
—
P/B Ratio
2.30
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-86.10 %
Last updated Oct 10, 2026, 9:02 PM

Hyperfine Peer Group

All fundamentals and in-depth analysis of Hyperfine

Our stock analysis for Hyperfine stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyperfine. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.